See All Slides - tctmd.com

Slides

Presentation TCT 2013

Allogeneic Cardiac-Derived Cells for STEMI

Presenter: Raj Makkar

October 29, 2013

Presentation TCT 2013

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Robert Whitbourn

October 29, 2013

Presentation TCT 2013

Selective Use of Intravascular Imaging and Physiologic Lesion Assessment to Improve Patient Outcomes

Presenter: Gary Mintz

October 29, 2013

Presentation

Treatment Options in Calcified Peripheral Vessels

Presenter: William Gray

October 29, 2013

Presentation TCT 2013

PCI vs CABG: Wait a Minute! These Lesions Need to Be Physiologically Evaluated Before Choosing Either!

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Presenter: Dariusz Dudek

October 29, 2013

Presentation

The Rostock/Berlin Real World Experience

Presenter: Stephan Kische

October 29, 2013

Presentation TCT 2013

The Science and Rationale of Bioabsorbable Vascular Scaffolds in the Treatment of Coronary Artery Disease

Presenter: Gabriel Maluenda

October 29, 2013

Presentation TCT 2013

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Presenter: Michael Maeng

October 29, 2013

Presentation

Coronary Artery Disease and CTA-Based Imaging: What Does It Mean?

Presenter: James Min

October 29, 2013

Advertisement

Slides

Allogeneic Cardiac-Derived Cells for STEMI

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Selective Use of Intravascular Imaging and Physiologic Lesion Assessment to Improve Patient Outcomes

Treatment Options in Calcified Peripheral Vessels

PCI vs CABG: Wait a Minute! These Lesions Need to Be Physiologically Evaluated Before Choosing Either!

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

The Rostock/Berlin Real World Experience

The Science and Rationale of Bioabsorbable Vascular Scaffolds in the Treatment of Coronary Artery Disease

TCT-12. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents

Coronary Artery Disease and CTA-Based Imaging: What Does It Mean?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content